Abstract

BackgroundHeadache disorders and psychiatric disorders are both common, while evidence, mostly pertaining to migraine, suggests they are comorbid more often than might be expected by chance. There are good reasons for establishing whether they are: symptoms of comorbid illnesses may summate synergistically; comorbidities hinder management, negatively influencing outcomes; high-level comorbidity indicates that, where one disease occurs, the other should be looked for. The Eurolight project gathered population-based data on these disorders from 6624 participants.MethodsEurolight was a cross-sectional survey sampling from the adult populations (18–65 years) of 10 EU countries. We used data from six. The questionnaire included headache-diagnostic questions based on ICHD-II, the Headache-Attributed Lost Time (HALT) questionnaire, and HADS for depression and anxiety. We estimated odds ratios (ORs) to show associations between migraine, tension-type headache (TTH) or probable medication-overuse headache (pMOH) and depression or anxiety.ResultspMOH was most strongly associated with both psychiatric disorders: for depression, ORs (vs no headache) were 5.5 [2.2–13.5] (p < 0.0001) in males, 5.5 [2.9–10.5] (p < 0.0001) in females; for anxiety, ORs were 10.4 [4.9–21.8] (p < 0.0001) and 7.1 [4.5–11.2] (p < 0.0001). Migraine was also associated with both: for depression, ORs were 2.1 [1.3–3.4] (p = 0.002) and 1.8 [1.1–3.1] (p = 0.030); for anxiety 4.2 [2.8–6.3] (p < 0.0001) and 2.4 [1.7–3.4] (p < 0.0001). TTH showed associations only with anxiety: ORs 2.5 [1.7–3.7] (p < 0.0001) for males, 1.5 [1.1–2.1] (p = 0.021) for females. Participants with migraine carried 19.1 % probability of comorbid anxiety, 6.9 % of depression and 5.1 % of both, higher than the representative general-population sample (14.3, 5.6 and 3.8 %). Probabilities in those with MOH were 38.8, 16.9 and 14.4 %; in TTH, they did not exceed those of the whole sample. Comorbid psychiatric disorder did not add to headache-attributed productive time losses, but weak associations existed (R2 = 0.020–0.082) for all headache types between lost productive time and probabilities of depression and, less so, anxiety.ConclusionIn this large study we confirmed that depression and especially anxiety are comorbid more than by chance with migraine, and showed the same is true, but more strongly, with MOH. Arguably, migraine patients and, more certainly, MOH patients should be screened with HADS in pursuit of best outcomes.

Highlights

  • Headache disorders and psychiatric disorders are both common, while evidence, mostly pertaining to migraine, suggests they are comorbid more often than might be expected by chance

  • Anxiety in the total sample was 2.5 times more prevalent than depression. This ratio was reduced to 1.7:1 in the subsample with no headache. Both disorders were more prevalent among females: depression by a ratio of 1.2:1 (p = 0.0406), anxiety more so, by 1.8:1 (p < 0.0001; Fisher’s exact test)

  • The analyses suggested that all associations, except that between depression and probable medication-overuse headache (pMOH), were stronger in males than in females

Read more

Summary

Introduction

Headache disorders and psychiatric disorders are both common, while evidence, mostly pertaining to migraine, suggests they are comorbid more often than might be expected by chance. In the Global Burden of Disease Study 2010 (GBD2010), tension-type headache (TTH) and migraine were found to be the second and third most prevalent disorders in the world [1]. Headache disorders are disabling: in GBD2013, they were revealed as the third cause of disability worldwide [4, 5], migraine and MOH being the substantial contributors. In GBD2013, depression and anxiety, both common psychiatric disorders, were ranked second and ninth highest causes of disability worldwide [4]. Few studies have considered TTH, people with episodic TTH were found no more likely than controls to experience anxiety or mood disorders [13], while those among a Chinese elderly population with chronic TTH were twice as likely to be suffering from depression [14]. There is evidence associating psychiatric morbidity with medication overuse [15], but no data on psychiatric comorbidity with MOH in the general population

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.